Strategizing the Development of Alzheimer’s Therapeutics
نویسندگان
چکیده
Alzheimer’s Disease is a complex, progressive condition with symptoms that do not reveal themselves until significant changes to neuronal morphology have already occurred. The delayed manifestation of cognitive decline makes determination of the true etiological origins difficult. As a result, identification of ideal drug targets becomes seemingly impossible. The existing treatments for Alzheimer’s Disease may temporarily suppress the rate of cognitive decline, but do little to slow or halt neuronal decay. While many believe that the current approaches to identifying a cure for the disease are too narrow-minded, focusing heavily on the physical manifestations of the diseased brain such as amyloid plaques and neurofibrillary tangles, this review asserts the status of Alzheimer’s research as rational and multi-faceted.
منابع مشابه
NEP, ACE and Homologues: The Pathophysiology of Membrane Metalloproteases
The zinc metalloprotease, neprilysin (NEP), plays a role in the metabolism of cardiovascular, inflammatory and neuropeptides, including mitogenic peptides such as bombesin. In the cardiovascular system, NEP has a primary role in the inactivation of natriuretic peptides but also contributes to local metabolism of angiotensin, endothelins and bradykinin. Hence NEP is seen as a potential therapeut...
متن کاملStrategizing vs. economizing: Theorizing dynamic competitive behavior in disequilibrium
1. Introduction 2. Profits are earned in disequilibrium Perfectly competitive equilibrium Assumptions of PCE PCE vs. dynamic strategic positioning (DSP) Profits as residual: Categories of income Measures of entrepreneurial profit 3. The firm as vehicle of strategizing behavior The elemental attributes of the strategizing firm The firm in the dynamic resource economy Strategizing around activiti...
متن کاملStrategizing Slum Improvement in India: A Method to Monitor and Refocus Slum Development Programs
متن کامل
Alzheimer’s Disease: Current and Future Treatments. A Review
Alzheimer’s disease (AD) is a currently incurable neurodegenerative disorder whose treatment poses a big challenge. Proposed causes of AD include the cholinergic, amyloid and tau hypotheses. Current therapeutic treatments have been aimed at dealing with the neurotransmitter imbalance. These include cholinesterase inhibitors and N-Methyl-D-aspartate (NMDA) antagonists. However, current therapeut...
متن کاملAntioxidant Property of Jobelyn as the Possible Mechanism Underlying its Anti-amnesic Activity in Rodents
Introduction: Amnesia or loss of memory is the cardinal hallmark of Alzheimer’s disease (AD), a progressive neurodegenerative disorder associated with ageing process. Although, AD had been discovered over a century ago, drugs which could cure or halt the progression of the disease are yet to see the light of the day. However, there has been a growing interest in the use of phytomedicines with m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014